U.S. Tariffs and Vitamin Products Exemption
On 2 April 2025, the United States government announced the imposition of a 34% tariff on imported goods from China. However, a significant exemption was granted to major vitamin products, allowing them to remain tariff-free. This decision provides relief to Chinese vitamin exporters amid otherwise escalating trade tensions.
New Product Approvals and Innovations
On 1 April 2025, Minglei Weisheng achieved a milestone as the National Medical Products Administration (NMPA) approved its marketing application for vitamin K1 drops for newborns. This innovative product is expected to fill a critical healthcare gap and strengthen Minglei Weisheng’s market presence.
Company Financial Updates
In April 2025, two prominent vitamin producers disclosed their financial results for the year 2024, reflecting broader trends within the Chinese vitamin sector. Detailed performance metrics signal varying operational strategies and market adaptability among leading companies.
Project Launches and Expansions
- Garden Biopharma: On 7 April 2025, Garden Biopharma announced that its major investment construction projects—biotin and vitamin B6 production lines—are expected to commence operations in Q2 and Q3 of 2025. These expansions are poised to boost supply capacity and strengthen the company’s competitive edge.
- Haineng Bioengineering: On 1 April 2025, Haineng Bioengineering hosted a high-profile launch event for its new 25-hydroxyvitamin D3 products, demonstrating its commitment to innovation and specialty nutrition solutions.
- Guangji Pharmaceutical: In April 2025, Guangji Pharmaceutical published the acceptance test report for its comprehensive utilization project producing 1,000 tons/year (1%) of vitamin B12. This project aims to optimize resource efficiency and scale production sustainably.
- Yize Pharmaceutical: On 28 March 2025, the Wuhai Municipal Ecological Environment Bureau publicized its approval opinion for Yize Pharmaceutical’s environmental impact assessment (EIA) regarding the production of:
- 1,500 tons/year monohydrate creatine
- 1,500 tons/year benzene phosphorothiamine and intermediates
- 1,000 tons/year crude vitamin B6 and intermediates such as heptane and oxazole
This approval facilitates Yize Pharmaceutical’s strategic manufacturing expansions, aligning with growing demand in both domestic and international markets.
Strategic Cooperation Agreements
- Cosmax China and Xinhai Bio: On 26 March 2025, Cosmax China formally signed a strategic cooperation memorandum with Xinhai Bio. The partnership aims to deepen collaboration across vitamin R&D, production, and global market expansion initiatives.
Industry Outlook
The developments in April 2025 reflect an industry actively evolving through technological innovation, strategic investments, and partnerships. With the U.S. tariff exemptions safeguarding vital export pathways and new projects coming online, China’s vitamin sector is positioned for continued growth despite global uncertainties.
Stay Ahead in the Vitamin and Nutritional Ingredients Market with China Informatics
The global vitamin and nutraceutical markets are evolving fast. Are you keeping pace?
China Informatics offers the critical intelligence you need to lead in Chinese vitamins, biopharma, and functional nutrition markets.
Exclusive Data on Vitamin Production and Export Trends
Get the latest figures on China’s vitamin B1, B6, B12, K1, biotin, 25-hydroxyvitamin D3, and related intermediates production and trade.
Real-Time Policy and Regulatory Monitoring
Navigate shifting regulations like NMPA approvals, environmental impact assessments, and U.S. tariff developments with our expert updates.
Company Profiles and Strategic Moves
Track emerging leaders like Guangji Pharmaceutical, Garden Biopharma, Yize Pharmaceutical, and others. Access financials, project details, and strategic partnership insights.
Customizable Intelligence Solutions
Tailored analysis for raw material sourcing, manufacturing expansions, export strategies, and M&A opportunities in the vitamin sector.
Why Industry Leaders Trust China Informatics:
- Precision data built for decision-makers
- Timely insights into policy, production, and trade
- Deep China market expertise, global relevance
Stay informed. Stay competitive.
[Request a Free Sample Report] | [Subscribe to Our Vitamin Industry Intelligence Now]
